Glenmark Pharmaceuticals Limited’s (GLENMARK) Moving Averages Convergence Divergence (MACD) indicator is 92.38, suggesting Glenmark Pharmaceuticals Limited is a Sell.
Glenmark Pharmaceuticals Limited’s (GLENMARK) 20-Day exponential moving average is 2,458.13, while Glenmark Pharmaceuticals Limited’s (GLENMARK) share price is ₹2,643.00, making it a Buy.
Glenmark Pharmaceuticals Limited’s (GLENMARK) 50-Day exponential moving average is 2,383.54, while Glenmark Pharmaceuticals Limited’s (GLENMARK) share price is ₹2,643.00, making it a Buy.
Glenmark Pharmaceuticals Limited’s (GLENMARK) 10-Day exponential moving average is 2,548.50, while Glenmark Pharmaceuticals Limited’s (GLENMARK) share price is ₹2,643.00, making it a Buy.
Glenmark Pharmaceuticals Limited’s (GLENMARK) 100-Day exponential moving average is 2,332.49, while Glenmark Pharmaceuticals Limited’s (GLENMARK) share price is ₹2,643.00, making it a Buy.
Glenmark Pharmaceuticals Limited’s (GLENMARK) stock price is ₹2,643.00 and Glenmark Pharmaceuticals Limited’s (GLENMARK) 50-day simple moving average is 2,379.95, creating a Buy signal.
Glenmark Pharmaceuticals Limited’s (GLENMARK) stock price is ₹2,643.00 and Glenmark Pharmaceuticals Limited’s (GLENMARK) 100-day simple moving average is 2,323.47, creating a Buy signal.
Glenmark Pharmaceuticals Limited’s (GLENMARK) stock price is ₹2,643.00 and Glenmark Pharmaceuticals Limited’s (GLENMARK) 200-day simple moving average is 2,245.82, creating a Buy signal.